Literature DB >> 6690363

Adenocarcinoma in Barrett's esophagus after elimination of gastroesophageal reflux.

S R Hamilton, D F Hutcheon, W J Ravich, J L Cameron, M Paulson.   

Abstract

A 56-yr-old man with severe reflux esophagitis, Barrett's esophagus, and a peptic lower esophageal stricture underwent subtotal resection of the Barrett's esophagus with colonic interposition. After the interposition procedure, gastroesophageal reflux was eliminated, as evidenced by absence of clinical and radiographic findings and by the results of a later continuous pH probe recording. Despite the absence of reflux, 8 yr after the colonic interposition the patient was found to have adenocarcinoma in the remnant of the Barrett's esophagus. This case indicates that elimination of gastroesophageal reflux does not necessarily lead to regression of Barrett's mucosa, nor does it prevent development of adenocarcinoma. As a result, patients with Barrett's esophagus should remain under long-term surveillance for dysplasia and adenocarcinoma, even after successful antireflux therapy. If esophagectomy is performed, every attempt should be made to resect all of the esophagus lined by Barrett's mucosa.

Entities:  

Mesh:

Year:  1984        PMID: 6690363

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

1.  Combination of endoscopic argon plasma coagulation and antireflux surgery for treatment of Barrett's esophagus.

Authors:  H Tigges; K H Fuchs; J Maroske; M Fein; S M Freys; J Müller; A Thiede
Journal:  J Gastrointest Surg       Date:  2001 May-Jun       Impact factor: 3.452

2.  Progression of Barrett's mucosa to adenocarcinoma after antireflux surgery: radiologic-pathologic correlation.

Authors:  F P Agha
Journal:  Dysphagia       Date:  1987       Impact factor: 3.438

3.  Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy.

Authors:  R F Heitmiller; M Redmond; S R Hamilton
Journal:  Ann Surg       Date:  1996-07       Impact factor: 12.969

4.  Cost effectiveness of detecting Barrett's cancer.

Authors:  T A Wright; M R Gray; A I Morris; I T Gilmore; A Ellis; H L Smart; M Myskow; J Nash; R J Donnelly; A N Kingsnorth
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

Review 5.  Management of refractory and complicated reflux esophagitis.

Authors:  B I Hirschowitz
Journal:  Yale J Biol Med       Date:  1996 May-Jun

Review 6.  Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management.

Authors:  H J Stein; J R Siewert
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

7.  The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus.

Authors:  M R Gray; R J Donnelly; A N Kingsnorth
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

8.  Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls.

Authors:  B I Hirschowitz
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

Review 9.  Barrett's oesophagus: optimal strategies for prevention and treatment.

Authors:  Ronnie Fass; Richard E Sampliner
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases.

Authors:  J M Streitz; F H Ellis; S P Gibb; K Balogh; E Watkins
Journal:  Ann Surg       Date:  1991-02       Impact factor: 12.969

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.